Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2005, p. 3011-3013, Vol. 49, No. 7
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.7.3011-3013.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institute of Medical Microbiology, National Reference Centre for Streptococci, University of Aachen (RWTH-Aachen), Aachen, Germany
Received 11 February 2005/ Returned for modification 10 March 2005/ Accepted 15 March 2005
By use of a time-kill methodology, the antipneumococcal activity of telithromycin was determined against macrolide-resistant S. pneumoniae isolates having mutations in the 23S rRNA gene and changes in the ribosomal proteins L4 and L22. Telithromycin had MICs ranging between 0.03 and 0.25 µg/ml and was bactericidal against four of seven strains after 24 h at two times the MIC.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |